NOVAVAX INC Shares Outstanding (Cover Page)
NOVAVAX INC (NVAX) had Shares Outstanding (Cover Page) of 164.95 million shares as of 2026-07-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-31: Entity Common Stock, Shares Outstanding 164.95M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 164.44M shares.
- 2026-02-16: Entity Common Stock, Shares Outstanding 162.94M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 162.50M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 164.95M shares 10-Q · filed 2026-08-06 |
| 2026-04-30 | 164.44M shares 10-Q · filed 2026-05-06 |
| 2026-02-16 | 162.94M shares 10-K · filed 2026-02-26 |
| 2025-10-31 | 162.50M shares 10-Q · filed 2025-11-06 |
| 2025-07-31 | 162.42M shares 10-Q · filed 2025-08-06 |
| 2025-04-30 | 161.97M shares 10-Q · filed 2025-05-08 |
| 2025-02-18 | 160.84M shares 10-K · filed 2025-02-27 |
| 2024-10-31 | 160.18M shares 10-Q · filed 2024-11-12 |
| 2024-07-31 | 160.09M shares 10-Q · filed 2024-08-08 |
| 2024-04-30 | 140.40M shares 10-Q · filed 2024-05-10 |
| 2024-02-23 | 139.95M shares 10-K · filed 2024-02-28 |
| 2023-10-31 | 118.79M shares 10-Q · filed 2023-11-09 |
| 2023-07-31 | 94.40M shares 10-Q · filed 2023-08-08 |
| 2023-04-30 | 86.31M shares 10-Q · filed 2023-05-09 |
| 2023-02-21 | 86.17M shares 10-K · filed 2023-02-28 |
| 2022-10-31 | 78.50M shares 10-Q · filed 2022-11-09 |
| 2022-07-31 | 78.22M shares 10-Q · filed 2022-08-09 |
| 2022-04-30 | 78.13M shares 10-Q · filed 2022-05-10 |
| 2022-02-21 | 76.28M shares 10-K · filed 2022-03-01 |
| 2021-10-31 | 75.61M shares 10-Q · filed 2021-11-05 |
| 2021-07-31 | 74.48M shares 10-Q · filed 2021-08-05 |
| 2021-04-30 | 74.09M shares 10-Q · filed 2021-05-10 |
| 2021-04-27 | 74.09M shares 10-K/A · filed 2021-04-30 |
| 2021-02-24 | 73.86M shares 10-K · filed 2021-03-01 |
| 2020-10-31 | 63.66M shares 10-Q · filed 2020-11-10 |
| 2020-07-31 | 61.28M shares 10-Q · filed 2020-08-10 |
| 2020-04-30 | 57.96M shares 10-Q · filed 2020-05-11 |
| 2020-03-06 | 51.53M shares 10-K · filed 2020-03-11 |
| 2019-10-31 | 26.58M shares 10-Q · filed 2019-11-07 |
| 2019-07-31 | 23.92M shares 10-Q · filed 2019-08-07 |
| 2019-04-25 | 469.45M shares 10-Q · filed 2019-05-02 |
| 2019-03-12 | 441.34M shares 10-K · filed 2019-03-18 |
| 2018-10-31 | 382.85M shares 10-Q · filed 2018-11-07 |
| 2018-08-03 | 382.59M shares 10-Q · filed 2018-08-08 |
| 2018-04-30 | 381.67M shares 10-Q · filed 2018-05-09 |
| 2018-03-09 | 343.74M shares 10-K · filed 2018-03-14 |
| 2017-10-31 | 313.62M shares 10-Q · filed 2017-11-07 |
| 2017-07-31 | 294.18M shares 10-Q · filed 2017-08-08 |
| 2017-04-30 | 282.61M shares 10-Q · filed 2017-05-08 |
| 2017-02-23 | 271.95M shares 10-K · filed 2017-02-27 |
| 2016-10-31 | 271.25M shares 10-Q · filed 2016-11-09 |
| 2016-07-31 | 271.19M shares 10-Q · filed 2016-08-09 |
| 2016-04-30 | 270.78M shares 10-Q · filed 2016-05-05 |
| 2016-02-24 | 270.31M shares 10-K · filed 2016-02-29 |
| 2015-10-31 | 269.86M shares 10-Q · filed 2015-11-09 |
| 2015-07-31 | 269.64M shares 10-Q · filed 2015-08-10 |
| 2015-04-30 | 268.03M shares 10-Q · filed 2015-05-07 |
| 2015-02-23 | 239.38M shares 10-K · filed 2015-02-27 |
| 2014-10-31 | 238.48M shares 10-Q · filed 2014-11-06 |
| 2014-07-31 | 238.41M shares 10-Q · filed 2014-08-07 |
| 2014-04-30 | 209.28M shares 10-Q · filed 2014-05-08 |
| 2014-03-06 | 209.06M shares 10-K · filed 2014-03-12 |
| 2013-10-31 | 208.51M shares 10-Q · filed 2013-11-12 |
| 2013-07-30 | 152.72M shares 10-Q · filed 2013-08-08 |
| 2013-04-30 | 152.46M shares 10-Q · filed 2013-05-09 |
| 2013-03-04 | 147.94M shares 10-K · filed 2013-03-12 |
| 2012-10-31 | 147.94M shares 10-Q · filed 2012-11-09 |
| 2012-07-31 | 133.68M shares 10-Q · filed 2012-08-09 |
| 2012-04-30 | 122.15M shares 10-Q · filed 2012-05-09 |
| 2012-03-08 | 121.57M shares 10-K · filed 2012-03-14 |
| 2011-10-31 | 114.97M shares 10-Q · filed 2011-11-08 |
| 2011-07-31 | 115.12M shares 10-Q · filed 2011-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |